Literature DB >> 28562080

Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study.

Taha Omer1, Eoin Finegan1, Siobhan Hutchinson2, Mark Doherty3, Alice Vajda1, Russell L McLaughlin3, Niall Pender1, Orla Hardiman1, Peter Bede1.   

Abstract

Frontotemporal dementia is associated with considerable clinical, genetic and pathological heterogeneity. The objective of this study is to characterise the imaging signatures of the main FTD phenotypes along the ALS-FTD spectrum. A total of 100 participants underwent comprehensive multimodal neuroimaging, genetic testing and neuropsychological evaluation. Seven patients with behavioural variant FTD (bvFTD), 11 patients with non-fluent-variant primary progressive aphasia (nfvPPA), two patients with sematic-variant primary progressive aphasia(svPPA), 10 patients with amyotrophic lateral sclerosis and FTD carrying the C9orf72 hexanucleotide repeat (C9 + ALS-FTD), 10 patients with ALS-FTD without hexanucleotide repeats (C9-ALS-FTD), 20 ALS patients without behavioural or cognitive deficits (ALSnci) and 40 healthy controls (HC) were included in a prospective quantitative neuroimaging study. Phenotype-specific spatial patterns of pathology were identified along the ALS-FTD spectrum, highlighting a strikingly focal distribution of disease burden as opposed to global atrophy. Significant motor cortex and corticospinal tract degeneration was identified in both bvFTD and nfvPPA patients. C9-ALS-FTD patients exhibited widespread extramotor pathology and significant precentral gyrus atrophy compared to ALSnci patients. ROI analyses confirmed focal grey matter alterations in Broca's and Wernicke's area in language variant FTD cohorts. Our findings confirm that the clinical manifestations of FTD are underpinned by phenotype-specific patterns of white and grey matter degeneration.

Entities:  

Keywords:  Magnetic resonance imaging; neurodegeneration; neuroimaging

Mesh:

Year:  2017        PMID: 28562080     DOI: 10.1080/21678421.2017.1332077

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  34 in total

Review 1.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

2.  Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis.

Authors:  Pilar M Ferraro; Corrado Cabona; Giuseppe Meo; Claudia Rolla-Bigliani; Lucio Castellan; Matteo Pardini; Matilde Inglese; Claudia Caponnetto; Luca Roccatagliata
Journal:  Neuroradiology       Date:  2021-03-04       Impact factor: 2.804

3.  Extra-motor cerebral changes and manifestations in primary lateral sclerosis.

Authors:  Eoin Finegan; Stacey Li Hi Shing; Rangariroyashe H Chipika; Kai Ming Chang; Mary Clare McKenna; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Niall Pender; Colette Donaghy; Siobhan Hutchinson; Russell L McLaughlin; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-07       Impact factor: 3.978

Review 4.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

5.  Heterogeneity of behavioural and language deficits in FTD-MND.

Authors:  Zhe Long; Muireann Irish; David Foxe; John R Hodges; Olivier Piguet; James R Burrell
Journal:  J Neurol       Date:  2021-02-20       Impact factor: 4.849

Review 6.  Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration.

Authors:  Rangariroyashe H Chipika; Grainne Mulkerrin; Pierre-François Pradat; Aizuri Murad; Fabrice Ango; Cédric Raoul; Peter Bede
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

7.  Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD.

Authors:  Elena Ratti; Kimiko Domoto-Reilly; Christina Caso; Alyssa Murphy; Michael Brickhouse; Daisy Hochberg; Nikos Makris; Merit E Cudkowicz; Bradford C Dickerson
Journal:  Brain Imaging Behav       Date:  2021-02-15       Impact factor: 3.224

8.  Gray matter changes in asymptomatic C9orf72 and GRN mutation carriers.

Authors:  Karteek Popuri; Emma Dowds; Mirza Faisal Beg; Rakesh Balachandar; Mahadev Bhalla; Claudia Jacova; Adrienne Buller; Penny Slack; Pheth Sengdy; Rosa Rademakers; Dana Wittenberg; Howard H Feldman; Ian R Mackenzie; Ging-Yuek R Hsiung
Journal:  Neuroimage Clin       Date:  2018-02-17       Impact factor: 4.881

9.  Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.

Authors:  Marlene Tahedl; Rangariroyashe H Chipika; Jasmin Lope; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

Review 10.  The Clinical and Radiological Spectrum of Hippocampal Pathology in Amyotrophic Lateral Sclerosis.

Authors:  Foteini Christidi; Efstratios Karavasilis; Georgios Velonakis; Panagiotis Ferentinos; Michail Rentzos; Nikolaos Kelekis; Ioannis Evdokimidis; Peter Bede
Journal:  Front Neurol       Date:  2018-07-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.